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ABSTRACT: Short-form ATP phosphoribosyltransferase
(ATPPRT) is a hetero-octameric allosteric enzyme comprising
four catalytic subunits (HisGS) and four regulatory subunits
(HisZ). ATPPRT catalyzes the Mg2+-dependent condensation of
ATP and 5-phospho-α-D-ribosyl-1-pyrophosphate (PRPP) to
generate N1-(5-phospho-β-D-ribosyl)-ATP (PRATP) and pyro-
phosphate, the ﬁrst reaction of histidine biosynthesis. While HisGS
is catalytically active on its own, its activity is allosterically
enhanced by HisZ in the absence of histidine. In the presence of
histidine, HisZ mediates allosteric inhibition of ATPPRT. Here,
initial velocity patterns, isothermal titration calorimetry, and diﬀerential scanning ﬂuorimetry establish a distinct kinetic
mechanism for ATPPRT where PRPP is the ﬁrst substrate to bind. AMP is an inhibitor of HisGS, but steady-state kinetics and
31P NMR spectroscopy demonstrate that ADP is an alternative substrate. Replacement of Mg2+ by Mn2+ enhances catalysis by
HisGS but not by the holoenzyme, suggesting diﬀerent rate-limiting steps for nonactivated and activated enzyme forms. Density
functional theory calculations posit an SN2-like transition state stabilized by two equivalents of the metal ion. Natural bond
orbital charge analysis points to Mn2+ increasing HisGS reaction rate via more eﬃcient charge stabilization at the transition state.
High solvent viscosity increases HisGS’s catalytic rate, but decreases the hetero-octamer’s, indicating that chemistry and product
release are rate-limiting for HisGS and ATPPRT, respectively. This is conﬁrmed by pre-steady-state kinetics, with a burst in
product formation observed with the hetero-octamer but not with HisGS. These results are consistent with an activation
mechanism whereby HisZ binding leads to a more active conformation of HisGS, accelerating chemistry beyond the product
release rate.
Allosteric control of catalysis is a widespread strategyevolved in biosynthetic pathways.1−4 The modulation of
biochemical pathways for synthetic biology applications often
requires overcoming or manipulating allosteric regulation.5,6
Furthermore, allosteric sites provide a more selective avenue
for drug design in comparison with active sites, which tend to
be more conserved.3,7,8 Accordingly, the elucidation of
allosteric mechanisms in multiprotein enzymatic complexes
paves the way for future therapeutic and biotechnological
applications.
The allosteric enzyme adenosine 5′-triphosphate phosphor-
ibosyltransferase (ATPPRT) (EC 2.4.2.17), responsible for the
ﬁrst and ﬂux-controlling step in histidine biosynthesis,9 is a
potential drug target in some pathogenic organisms,8,10−12 the
focus of synthetic biology endeavors to harness the histidine
biosynthetic pathway for histidine production in bacteria,6,13,14
and a model system for the study of allosteric regulation of
catalysis.3,8,15,16
ATPPRT catalyzes the Mg2+-dependent and reversible
nucleophilic substitution of adenosine 5′-triphosphate (ATP)
N1 on 5-phospho-α-D-ribosyl-1-pyrophosphate (PRPP) C1 to
generate N1-(5-phospho-β-D-ribosyl)-ATP (PRATP) and
inorganic pyrophosphate (PPi) (Scheme 1),
9 with the chemical
equilibrium highly displaced toward reactants.17 The metabolic
status of the cell regulates ATPPRT activity via allosteric
inhibition by histidine9,18 and orthosteric inhibition by
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adenosine 5′-monophosphate (AMP).19 Intriguingly, orthos-
teric inhibition by adenosine 5′-diphosphate (ADP) is also
reported.19
The hisG gene encodes two forms of ATPPRT. Most
histidine-synthesizing organisms possess a long-form of the
protein, HisGL,
16,20 a homohexamer with each subunit
consisting of two N-terminal catalytic domains and a C-
terminal allosteric domain responsible for histidine inhib-
ition.11 HisGL ATPPRTs operate by a steady-state ordered
kinetic mechanism where ATP is the ﬁrst substrate to bind to,
and PRATP the last product to dissociate from, the
enzyme.21,22
Archaea and some eubacteria have instead a short-form of
the protein, HisGS,
23,24 a homodimer with each subunit
comprising two catalytic domains homologous to HisGL’s, but
lacking the C-terminal allosteric domain.20,25 Thus, HisGS is
catalytically active on its own but insensitive to inhibition by
histidine.20,26 HisGS binds HisZ, the product of the hisZ gene,
a catalytically inactive paralogue of histidyl-tRNA synthetase,23
forming the hetero-octameric ATPPRT holoenzyme, where
two HisGS dimers ﬂank a HisZ tetramer.
24,26,27 HisZ has two
distinct allosteric functions: in the absence of histidine, it
activates catalysis by HisGS, and in the presence of histidine, it
binds the ﬁnal product of the pathway and mediates allosteric
inhibition of HisGS.
20,24,26,28 The kinetic mechanism of HisGS
ATPPRTs has not been investigated, but recent crystal
structures suggest that the order of substrate binding may be
diﬀerent from HisGL’s.
29 Moreover, little is known about the
kinetics of allosteric activation.
We recently reported several crystal structures of the
psychrophilic bacterium Psychrobacter arcticus dimeric HisGS
(PaHisGS) and hetero-octameric ATPPRT holoenzyme
(PaATPPRT),26,29 from which an activation mechanism was
inferred that involves tightening of the PaHisGS dimer in the
hetero-octamer when both substrates are bound (Figure 1),
which facilitates leaving group stabilization at the transition
state.29 Here we employ initial rate studies, isothermal titration
calorimetry (ITC), diﬀerential scanning ﬂuorimetry (DSF), 31P
nuclear magnetic resonance (31P NMR), liquid chromatog-
raphy−mass spectrometry (LC-MS), density functional theory,
solvent viscosity eﬀects, and pre-steady-state kinetics to unveil
a distinct kinetic mechanism for PaATPPRT, the role of ADP
as a substrate instead of an inhibitor, the basis for charge-
stabilization at the transition state, and a shift in the rate-liming
step upon allosteric activation of the enzyme.
■ MATERIALS AND METHODS
Materials. ATP, PRPP, PPi, AMP, ADP, MgCl2, MnCl2,
D2O (99.9 atom % deuterium), tricine, dithiothreitol (DTT),
and glycerol were purchased from Sigma-Aldrich. All other
chemicals were purchased from readily available commercial
sources, and all chemicals were used without further
puriﬁcation. PaHisGS, PaHisZ, Mycobacterium tuberculosis
pyrophosphatase (MtPPase), and tobacco etch virus protease
were obtained as previously published.26 PRATP was produced
as previously described.29
PaHisGS and PaATPPRT Activity Assay. All assays were
performed under initial rate conditions in the forward direction
at 20 °C as previously described26 by monitoring the increase
in absorbance at 290 nm due to formation of PRATP (ε290 nm
= 3600 M−1 cm−1)30 in 1 cm path length quartz cuvettes
(Hellma) in a Shimadzu UV-2600 spectrophotometer. Unless
stated otherwise, for PaHisGS activity, PaHisGS concentration
was 2.2 μM, and for PaATPPRT activity, PaHisGS and PaHisZ
concentrations were 0.38 and 15 μM, respectively. Reactions
were started by addition of PRPP. Control reactions lacked
either ATP, PRPP, PaHisGS, or PaHisZ. In all kinetic
experiments under the various diﬀerent conditions described
below, controls were carried out to ensure that the rate did not
depend on MtPPase. Kinetic measurements were performed at
least in duplicates unless stated otherwise.
PaATPPRT Equilibrium Dissociation Constant (KD) in
Glycerol. Initial velocities were measured in the presence of
5.6 mM ATP, 2 mM PRPP, 0.38 μM PaHisGS, and varying
concentrations of PaHisZ (0.9−8.5 μM) in 0%, (0.5−16.3
μM) in 18% and 27% glycerol (v/v). PaHisZ-PaHisGS KD
values were obtained by ﬁtting initial rate data to a kinetic
equation (vide inf ra) as previously reported.26
PaATPPRT and PaHisGS Saturation Kinetics with ATP
and PRPP. PaATPPRT initial rates were measured at
saturating concentrations of one substrate and varying
concentrations of the other, either ATP (0.4−5.6 mM) or
PRPP (0.1−2.0 mM). Initial rates for PaHisGS were
determined at saturating concentrations of one substrate and
varying concentrations of the other, either ATP (either 0.4−
2.8 or 0.4−5.6 mM) or PRPP (0.1−2.0 mM).
PaATPPRT and PaHisGS Saturation Kinetics with
MnCl2. PaATPPRT initial rates were measured at saturating
concentrations of one substrate and varying concentrations of
the other, either ATP (0.1−1.4 mM) or PRPP (0.1−2.0 mM),
while initial rates for PaHisGS (1.1 μM) were determined at
saturating concentrations of one substrate and varying
concentrations of the other, either ATP (0.1−1.4 mM) or
PRPP (0.05−2.0 mM), in the presence of 15 mM MnCl2
instead of MgCl2.
Analysis of PaHisGS Reaction with MnCl2 by LC-MS.
Reaction mixtures (500 μL) contained 100 mM tricine pH 8.5,
100 mM KCl, 4 mM DTT, 15 mM MnCl2, 19.7 μM MtPPase,
1.4 mM ATP, 2.0 mM PRPP, and 10.3 μM PaHisGS. Reactions
were incubated for 1 h at 20 °C, after which proteins were
removed by passage through 10000 MWCO Vivaspin
centrifugal concentrators. Reactions were run in duplicate,
Figure 1. PaHisGS and PaATPPRT quaternary structures and
allosteric activation. (A) PaATPPRT hetero-octamer, where catalysis
is enhanced. The second PaHisGS homodimer is behind the PaHisZ
tetramer. (B) Nonactivated PaHisGS homodimer and (C) overlay of
activated and nonactivated PaHisGS dimers. In all structures, PaHisGS
is bound to PRPP, ATP, and Mg2+.29
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and control reactions lacked PaHisGS. LC-MS analysis of the
protein-free reaction mixtures was performed on an EC250/4.6
Nucleodur 100−10 C18 ec HPLC column (10 μm × 4.6 mm
× 250 mm) (Macherey-Nagel) in a 1260 inﬁnity HPLC system
coupled to a G6130B Single Quadrupole mass spectrometer
(Agilent Technologies). Separation of PRATP and ATP was
carried out in (A) 50 mM triethylamine-acetic acid pH 7.4 and
(B) methanol as a mobile phase in the following sequence: 0−
3 min 100% A, 3−3.1 min 90% A and 10% B, 3.1−12 min 80%
A and 20% B at a ﬂow rate of 1 mL min−1, with UV absorbance
monitored at 260 and 290 nm. Electrospray ionization-mass
spectrometry (ESI-MS) data were acquired in negative mode
with a capillary voltage of 4500 V.
PaATPPRT and PaHisGS Saturation Kinetics in
Glycerol. PaATPPRT and PaHisGS initial rates were
measured at saturating concentrations of one substrate and
varying concentrations of the other, either ATP (0.4−5.6 mM)
or PRPP (0.1−2.0 mM), in the presence of 0%, 18%, and 27%
glycerol (v/v).
PaHisGS Inhibition by AMP. The half-maximal inhibitory
concentration of AMP was determined by measuring initial
rates for PaHisGS (4.5 μM) in the presence of 5.6 mM ATP, 2
mM PRPP, and varying concentrations of AMP (0−0.8 mM).
The inhibition mechanism was investigated by measuring
initial rates for PaHisGS (4.5 μM) at saturating concentrations
of one substrate and varying concentrations of the other, either
ATP (0.4−5.6 mM) with diﬀerent concentrations of AMP (0−
0.1 mM) or PRPP (0.1−2.0 mM) with diﬀerent concentrations
of AMP (0−0.05 mM). PaHisGS concentration was more than
4-fold higher than the lowest AMP concentration used, and
pseudo-ﬁrst-order approximation was assumed.
PaHisGS Saturation Kinetics with ADP and PRPP.
Initial rates for PaHisGS were determined at saturating
concentrations of one substrate and varying concentrations
of the other, either ADP (0.4−5.6 mM) or PRPP (0.1−2.0
mM).
Comparison of PaHisGS Reactions with ADP and ATP
by 31P NMR Spectroscopy. Analysis of PaHisGS reactions by
31P NMR spectroscopy was carried out as previously
described,26 except that PaHisGS concentration was 10.3 μM
and ADP replaced ATP in half of the reactions. All reactions
were run in duplicate, and control reactions lacked PaHisGS.
PaATPPRT and PaHisGS Initial Velocity Patterns. Initial
rates for PaATPPRT were measured in the presence of varying
ATP (0.4−5.6 mM) and PRPP (0.1−2.0 mM), with 1 μM
PaHisGS and 20 μM PaHisZ. Initial rates for PaHisGS were
determined in the presence of varying ATP (0.2−2.8 mM) and
PRPP (0.1−2.0 mM). Measurements were performed in
quadruplicates.
PaHisGS Binding by ITC. ITC measurements were carried
out at 20 °C in a MicroCal PEAQ-ITC calorimeter (Malvern
Instruments). Protein and ligand were solubilized in the same
ATPPRT assay buﬀer. After a small injection of 0.4 μL, 18
successive injections of 2 μL of ligand (either 0.8 mM PRPP or
10 mM ATP) were made into 300 μL of 50 μM PaHisGS, with
150-s intervals between successive injections and a reference
power of 10 μcal s−1. Heat of dilution for each experiment was
measured by titrating ligand into assay buﬀer, and subtracted
from the corresponding binding curve. All measurements were
performed in duplicate. Data for PRPP binding were ﬁtted to a
single-site binding model as implemented in the PEAQ-ITC
analysis software (Malvern Instruments).
PaHisGS Thermal Denaturation by DSF. DSF measure-
ments (λex = 490 nm, λem 610 nm) were performed in 96-well
plates on a Stratagene Mx3005p instrument. Thermal
denaturation assays (50 μL) for 7.5 μM PaHisGS were
measured in the presence and absence of ligands (6 mM ATP,
2 mM PRPP, 208 μM PRATP, 3.6 mM PPi), with or without
22% glycerol (v/v) (apoenzyme) in 100 mM tricine, 100 mM
KCl, 4 mM DTT and 15 mM MgCl2 pH 8.5. The assay for
apoenzyme was also performed in 10 mM KH2PO4, 10 mM
KF pH 8.0. Sypro Orange (5×) (Invitrogen) was added to all
wells. Thermal denaturation curves were recorded over a
temperature range from 25−93 °C with 1 °C min−1
increments. Control curves lacked enzyme and were subtracted
from curves containing enzyme. All measurements were carried
out in triplicate.
Density Functional Theory Calculations. Theoretical
structures were derived from B3LYP calculations using a 6-
31G* basis set with a Lanl2DZ basis set on Mg2+ and Mn2+
and a Lanl2DZ pseudopotential added to Mg2+ and Mn2+ as
implemented in Gaussian 09.31 A model system was chosen by
including all residues within 5 Å of ADP and PRPP in the
crystallographic dimer of the PaHisGS-PRPP-Mg-ADP com-
plex crystal structure29 and by ﬂipping the adenine ring from
its crystal structure orientation to bring N1 in proximity to
PRPP. The system was further paired down to include only
functional groups, metal ions and water molecules within the
5-Å cutoﬀ that were essential for stabilization of the transition
structure. In addition to the divalent metal found in the crystal
structure, a second divalent metal had to be included in the
system for a transition structure to be located. Initial searches
exploring structures with ﬁxed distances along the reaction
coordinate were located by performing an optimization of an
input structure with the key bond-forming or bond-breaking
distances held constant, and frequency calculations resulted in
only one imaginary frequency along the reaction coordinate.
Final transition structures for the system complexed with either
Mg2+ or Mn2+ were located as stationary points with no
geometrical constrains and exhibit only one imaginary
frequency along the reaction coordinate. Coordinates for all
optimized structures are available in the Supporting
Information.
Pre-Steady-State Kinetics. Approach to steady-state in
PaHisGS and PaATPPRT reactions was investigated under
multiple-turnover conditions by monitoring the increase in
absorbance at 290 nm upon PRATP formation at 20 °C in an
Applied Photophysics SX-20 stopped-ﬂow spectrophotometer
outﬁtted with a 5 μL mixing cell (0.5 cm path length and 0.9
ms dead-time). Each syringe contained 100 mM tricine pH 8.5,
100 mM KCl, 4 mM DTT, 15 mM MgCl2, and 20 μM
MtPPase. In addition, one syringe carried 40 μM PaHisGS
(with or without 100 μM PaHisZ) and 4 mM PRPP, while the
other carried 11.2 mM ATP. Reaction was triggered by rapidly
mixing 55 μL from each syringe. Absorbance increase with
PaHisGS was monitored in a linear-time base for 5 s with 5000
data points collected, and with PaATPPRT, in a split-time base
for 2 s, with 4000 data points collected in the ﬁrst 0.2 s and
4000 in the following 1.8 s. At least 8 traces were acquired for
each enzyme, and controls lacked PRPP.
Data Analysis of Kinetics and Thermal Denaturation.
Kinetic and DSF data were analyzed by the nonlinear
regression function of SigmaPlot 13 (SPSS Inc.). Data points
and error bars in graphs are represented as mean ± standard
error, and kinetic and equilibrium constants are presented as
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mean ± ﬁtting error. Initial rate data with varying
concentrations of PaHisZ were ﬁtted to eq 1. The
concentration of PaATPPRT at any concentration of PaHisGS
and PaHisZ was calculated according to eq 2. Substrate
saturation data were ﬁtted to eq 3. Inhibition data at ﬁxed
substrate concentrations were ﬁtted to eq 4, and competitive
inhibition data were ﬁtted to eq 5. Initial velocity patterns were
ﬁtted to eq 6, and pre-steady-state kinetics under multiple-
turnover conditions was ﬁtted to eq 7. In eqs 1−7, v is the
initial rate, Vmax is the maximal velocity, G is the concentration
of PaHisGS, Z is the concentration of PaHisZ, KD is the
equilibrium dissociation constant, PaATPPRT is the concen-
tration of PaHisGS-PaHisZ complex, S is the concentration of
the varying substrate, kcat is the steady-state turnover number,
KM is the apparent Michaelis constant, ET is total enzyme
concentration, vi is the initial rate in the presence of inhibitor,
IC50 is the half-maximal inhibitory concentration, Ki is the
inhibitor dissociation constant, A and B are the ﬁrst and
second substrates to bind to the enzyme, respectively, Ka and
Kb are their respective Michaelis constants, Kia is the apparent
dissociation constant for the complex between enzyme and
substrate A when the concentration of B approaches zero, t is
time, P(t) is product concentration at time t, A0 is the
amplitude of the burst phase, and kburst is the ﬁrst-order rate
constant of product formation in the burst phase. DSF thermal
denaturation data were ﬁtted to eq 8,32 where FU is fraction
unfolded, T is the temperature in °C, Tm is the melting
temperature, c is the slope of the transition region, and LL and
UL are folded and unfolded baselines, respectively.
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■ RESULTS AND DISCUSSION
PaHisGS and PaATPPRT Kinetic Mechanism. A steady-
state ordered kinetic mechanism in which ATP is the ﬁrst
substrate to bind to the enzyme, and PRATP is the last
product to dissociate from it, has long been demonstrated for
HisGL ATPPRTs.
21,22 This mechanism has been supported by
several structures of Campylobacter jejuni and M. tuberculosis
ATPPRT-ATP binary complexes,10,16 and by the recent
structure of the C. jejuni ATPPRT catalytic core in complex
with PRPP, where despite being able to bind to the free
enzyme, PRPP drifts into the ATP binding site, which would
lead to a dead-end complex.33 The kinetic mechanism of
HisGS ATPPRTs, on the other hand, has not been explored.
We recently published the crystal structures of PaHisGS and
PaATPPRT in binary complexes with PRPP and PRATP, and
in ternary complexes with PRPP-ATP, but were unable to
obtain structures of enzyme-ATP binary complexes, suggesting
a reverse order of substrate binding in comparison with HisGL
ATPPRTs.29
To test this hypothesis, the kinetic mechanism of PaHisGS
and PaATPPRT was investigated. Intersecting patterns of
double-reciprocal plots with both ATP and PRPP in initial
velocity studies were determined for PaATPPRT (Figure
2A,B) and PaHisGS (Figure 2C,D), indicating a ternary
complex is formed in a sequential mechanism. The double-
reciprocal plots intersecting to the left of the y-axes rule out a
rapid equilibrium ordered mechanism.34 Fitting the data to eq
6 (Figure 2E,F) yielded steady-state kinetic parameters
summarized in Table S1.
Binding studies were performed with PaHisGS to elucidate
the substrate binding order. Binding of PRPP to PaHisGS was
detected by ITC (Figure S1), and ﬁtting the data from two
independent experiments to a single-site binding model
(stoichiometry of 1:1 and no cooperativity) resulted in KD's
of 15.4 ± 0.2 and 8.3 ± 0.1 μM (one from each experiment,
yielding a mean ± SE of 12 ± 2 μM). ATP binding to
PaHisGS, on the other hand, could not be detected, as no
signal was observed beyond heat of dilution (Figure S2). This
Figure 2. Initial velocity patterns for PaATPPRT and PaHisGS.
Intersecting double-reciprocal plots for PaATPPRT with (A) ATP
and (B) PRPP as varying substrates and for PaHisGS with (C) ATP
and (D) PRPP as varying substrates. Each color represents a diﬀerent
ﬁxed concentration of the cosubstrate. Data points are mean ± SE.
Three-dimensional plot of (E) PaATPPRT and (F) PaHisGS initial
rate data, where lines are data ﬁtting to eq 6.
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corroborates the hypothesis that PRPP can bind to the free
enzyme, while ATP cannot.
To conﬁrm and expand these results, PaHisGS thermal
denaturation curves in the presence and absence of substrates
and products were determined by DSF (Figure 3), and data
ﬁtting to eq 8 produced Tm’s shown in Table S2. PRPP and
PRATP increased PaHisGS Tm by 6 and 5 °C, respectively,
indicating that these molecules can bind to the free enzyme.
Conversely, ATP and PPi did not alter PaHisGS Tm. The latter
observation alone does not necessarily rule out the possibility
that ATP and PPi can bind to the free enzyme, but the
integration of crystallography,29 initial velocity patterns, ITC,
and DSF data supports a steady-state ordered mechanism
where PRPP is the ﬁrst substrate to bind to PaHisGS and
PRATP is the last product to dissociate from it. The strong
parallels in corresponding binding modes seen in the PaHisGS
and PaATPPRT crystal structures29 suggest that PaATPPRT
follows the same mechanism. Moreover, given the conservation
of PRPP position in PaATPPRT29 and Lactococcus lactis
ATPPRT binary complexes,27 this mechanism may be valid for
other HisGS ATPPRTs.
AMP Is an Inhibitor of PaHisGS. AMP is a competitive
inhibitor of HisGL ATPPRTs against both substrates,
16,19
which is explained structurally by the simultaneous partial
occupation of the PRPP and ATP binding sites by AMP’s
phosphoribosyl and adenine moieties, respectively.11,16,35 AMP
is also a competitive inhibitor against PRPP in L. lactis
ATPPRT,28 and the recent crystal structure of the PaHisGS-
AMP complex shows a similar binding mode as in HisGL
ATPPRTs.11,16,29,35 AMP inhibits PaHisGS with an IC50 of 79
± 6 μM (Figure S3A), and inhibition is competitive against
both PRPP and ATP, with Ki’s of 25 ± 5 and 52 ± 8 μM,
respectively (Figure S3B,C). These values are on average ca. 7-
and 10-fold lower than those for HisGL ATPPRTs,
16,19 and
over 27-fold lower than that for L. lactis ATPPRT,28 suggesting
PaHisGS activity is more stringently regulated by this
metabolite.
ADP Is a Substrate for PaHisGS. ADP has been shown to
be an inhibitor of HisGL ATPPRTs.
19 However, crystal
structures of PaHisGS and PaATPPRT in complex with
PRPP-ADP reveal that ADP binds in the same manner as
ATP.29 In order to evaluate the ability of PaHisGS to use ADP
as a substrate, we compared the reactions with ADP and ATP
by 31P NMR spectroscopy (Figure S4). The spectra of
reactions containing ADP (Figure S4A) and ATP (Figure
S4C) are similar except for the peak at −19.2 to −19.4
corresponding to the γ-PO4
2− phosphorus of ATP and PRATP,
since this group is absent in ADP and N1-(5-phospho-β-D-
ribosyl)-ADP (PRADP). Spectra for both reactions diﬀer from
the controls lacking PaHisGS (Figure S4B,D). The character-
istic peak at ca. 3.3 ppm corresponding to the phosphorus in
the N1-5-phospho-β-D-ribose moiety of the product26 is
present in the reaction spectra with ADP (Figure S4A, inset)
and ATP (Figure S4C, inset), and absent in the controls
(Figure S4B,D, insets), establishing that ADP can replace ATP
as a substrate for PaHisGS.
For a quantitative comparison of the reactions with ATP and
ADP, steady-state kinetic analysis of the reaction with either
substrate was carried out (Figure 4) and kinetic parameters are
summarized in Table S3. Values of kcat are the same within
error with either ATP or ADP as a substrate, indicating that
once saturated PaHisGS turns over ATP and ADP just as
eﬀectively. The main diﬀerence is in the KM for ADP, which is
over 3-fold that for ATP, suggesting some small loss of aﬃnity
for the steady-state with ADP.
PaHisGS and PaATPPRT Kinetics with Mn
2+. Replace-
ment of Mg2+ by Mn2+ is a common strategy in enzymology,36
having been employed to uncover rate-limiting steps in
reactions involving stabilization of phosphate groups.37
HisGL ATPPRTs have been reported to have their activities
either unaltered or decreased by changing the divalent metal in
the reaction from the physiological Mg2+ to Mn2+, but no
mechanistic inference has been drawn.17,38 To evaluate the
eﬀect of Mn2+ on a HisGS enzyme, saturation curves for
PaHisGS and PaATPPRT with either divalent metal were
determined (Figure 5), and kinetic constants are displayed in
Table S4. Mn2+ led to 2.6- and 11-fold increases in PaHisGS
kcat and kcat/KM
ATP, respectively, as compared with Mg2+. The
change in kcat/KM
ATP was driven in large part by a reduction in
KM
ATP. LC-MS analysis of the PaHisGS reaction with Mn
2+
conﬁrmed the same product, PRATP, was being formed
(Figure S5).
In contrast to PaHisGS, steady-state constants for
PaATPPRT were unchanged by Mn2+, except for a 2.9-fold
increase in kcat/KM
ATP owing to a reduction in KM
ATP. These
results raise the possibility that PaHisGS and PaATPPRT
reactions have distinct rate-limiting steps. Crystal structures of
PaHisGS and PaATPPRT with various ligands do not depict
any speciﬁc interaction between Mg2+ and the enzyme,29
raising the possibility the oﬀ-rates of products from the active
site might not be aﬀected by the nature of the metal ion. It is
possible, nonetheless, that a solution metal stabilizes charges of
either PRATP or PPi concomitantly with product release from
the enzyme. The metal ion seen in the structures acts as a
Lewis acid to stabilize negative charges in the Michaelis
complex upon binding of ATP, with a putative second metal
Figure 3. DSF-based thermal denaturation of PaHisGS apoenzyme
and in the presence of substrates and products. Thin black lines are
data ﬁtting to eq 8.
Figure 4. PaHisGS substrate saturation curves with either ATP
(green) or ADP (blue) as a substrate. (A) Varying PRPP
concentration with saturating concentration of the nucleotide. (B)
Varying the nucleotide concentration with saturating concentration of
PRPP. Data points are mean ± SE, and lines are data ﬁtting to eq 3.
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ion likely present at the transition state to facilitate departure
of the PPi leaving group.
29 Thus, one might expect Mn2+ to
increase the reaction rate if rate-limiting steps are located
between ATP binding to the enzyme-PRPP complex and
product formation, since a stronger Lewis acid would facilitate
catalysis by stabilizing charges more eﬃciently. The kinetic
constants aﬀected would be kcat and kcat/KM
ATP, which is
exactly what is observed with PaHisGS. If, on the other hand,
ternary complex formation played a minor role in limiting the
reaction rate, chemistry was fast, and product release was the
slowest step, a modest increase in kcat/KM
ATP only would be
expected, which is the case with PaATPPRT.
A Transition-State Hypothesis for the PaHisGS
Reaction. An SN1-like, DN*AN
‡39,40 transition-state structure
has recently been proposed for C. jejuni and M. tuberculosis
(HisGL) and L. lactis (HisGS) ATPPRT-catalyzed reaction
based on kinetic isotope eﬀects and computational chemistry,
using a simpliﬁed model of the reaction for density functional
theory calculations.10 Having established that PaHisGS utilizes
ADP as a substrate with a similar kcat as it does ATP (Table
S3), the crystal structure of the PaHisGS-PRPP-Mg-ADP
Michaelis complex29 served as a starting point for density
functional theory calculations in order to ﬁnd a theoretical
transition state for the reaction that includes not only the full
substrates but also several active-site residue side-chain
surrogates and water molecules essential to stabilize the
system, with either Mg2+ or Mn2+ as the metal ion (Figure 6).
Transition structures were located as stationary points (i.e.,
without any constraints on distances or dihedral angles) and
possess only one imaginary frequency reﬂecting vibration along
the N1−C1−O1 axis. Inclusion of a second equivalent of the
divalent metal ion to stabilize the departing PPi leaving group
was essential to locate transition structures, lending support to
a recent proposal based on the crystal structures of PaHisGS
and PaATPPRT Michaelis complexes29 and the transition
structures of other phosphoribosyltransferases.41
The optimized structures indicate an SN2-like, almost
synchronous ANDN transition state is possible for the
PaHisGS-catalyzed reaction with either Mg
2+ (Figure 6A) or
Mn2+ (Figure 6B) as a Lewis acid. The 6-NH2 group of ADP is
protonated in all transition structures and is likely to lose a
proton to form the 6-NH group of PRADP only after the
nucleophilic substitution is complete, as recently hypothe-
sized.29 Nucleophilic attack occurs from the charge-neutral
resonance structure of adenine in which N1 has transiently a
negative charge due to electron donation from N6. This
natural resonance structure represents 6.64% of the distribu-
Figure 5. Steady-state kinetics with Mg2+ (green) and Mn2+ (blue).
Saturation curves varying either PRPP or ATP concentration with
saturating concentration of the cosubstrate for (A and B) PaHisGS
and (C and D) PaATPPRT. Data points are mean ± SE, and lines are
data ﬁtting to eq 3.
Figure 6. Transition-state model for the PaHisGS-catalyzed reaction. (A) Transition structure with magnesium, (B) transition structure with
manganese, and (C) overlay of the transition structures with magnesium and manganese. Substrates are represented as stick models, side-chain
mimics as wireframe, and metal ions and water oxygens as spheres. Carbon is in either cyan or yellow for substrates and in gray for side-chain
mimics, with oxygen in red, nitrogen in blue, phosphorus in orange, magnesium in green, and manganese in purple. Hydrogens are omitted for
simplicity. Partial bonds and metal ion coordination bonds are represented by dashed lines. Distances are shown for the N1−C1 and the C1−O1
bonds. Key residue side-chain mimics are labeled, and the prime denotes a residue of the adjacent subunit in the PaHisGS dimer.
29
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tion of adenine resonances.42 The ANDN transition state
located here contrasts with the DN*AN
‡ one proposed for
HisGL and HisGS ATPPRT reaction.
10 This would mean that
diﬀerent orthologues of ATPPRT catalyze the same reaction
via diﬀerent transition states, which is not uncommon in
ribosyl-transfer reactions. For instance, distinct transition-state
models based on kinetic isotope eﬀects and density functional
theory have been suggested for bovine and human purine
nucleoside phosphorylases,43,44 and for wild-type and mutant
human purine nucleoside phosphorylases.43,45 Kinetic isotope
eﬀect measurements for PaHisGS could test the ANDN
transition-state hypothesis put forth in this work.
Overlay of the transition structures with Mg2+ and Mn2+
demonstrates an almost identical arrangement (Figure 6C),
indicating transition-state geometry cannot explain the
discrimination in PaHisGS reactivity between the metal ions.
Natural bond orbital (NBO) analysis of the transition
structures, however, revealed signiﬁcant diﬀerences in charge
distribution in the metal ions and the PPi at the transition state
depending on which metal is included (Table S5). Most atoms
have very similar charges in the two transition structures,
except for the metal ions and PPi oxygens. The average charge
of the two magnesium ions at the transition state is 1.439, over
2-fold higher than the average charge of the manganese ions,
0.649. This is due to more eﬃcient attenuation of the negative
charge of the PPi leaving group by Mn
2+ through d-orbital
bonding to coordinating oxygens, as shown by orbital
population analysis. As compared with Mg2+, therefore, Mn2+
improves catalysis in the PaHisGS reaction by more eﬀectively
stabilizing the negatively charged leaving group at the
transition state.
Solvent Viscosity Eﬀects on PaHisGS and PaATPPRT
Kinetics. In order to probe further the distinct rate-limiting
steps governing PaHisGS and PaATPPRT catalyses, the eﬀect
of solvent viscosity on reaction rates was evaluated (Figure 7),
and the data are summarized in Tables S6 and S7. Increasing
solvent viscosity by increasing glycerol concentration46 slows
down diﬀusional steps such as substrate binding and release
and product release, and values of kinetic constants will be
reduced if such steps are rate-limiting.47−49 PaHisGS rate
constants did not decrease with increasing glycerol concen-
tration (Table S6), consistent with diﬀusional steps not
contributing to limit the reaction rate. Instead, as shown in
Figure 7A and Table S6, glycerol led to an increase in PaHisGS
kcat and kcat/KM
PRPP of up to 2.7- and 2.4-fold, respectively,
while kcat/KM
ATP was only marginally aﬀected. Inverse solvent
viscosity eﬀects generally suggest that a more active dynamic
conformation of the enzyme or the Michaelis complex is
favored at high viscosity.47−49 To rule out the possibility that
glycerol might be aﬀecting the overall stability of the enzyme, a
thermal denaturation curve was determined by DSF in 22%
glycerol (Figure S6), and no diﬀerence in Tm was observed in
comparison with that determined without glycerol (Table S2).
Crystal structures of PaHisGS apoenzyme and PaHisGS-PRPP-
ATP were also obtained with and without soaking crystals in
glycerol, and no electron density for glycerol was visualized in
any of the structures.29 This suggests that glycerol is acting as
part of bulk solvent, not as a ligand, but with the caveat that
crystal lattice might have prevented binding.
To assess the eﬀect of solvent viscosity on PaATPPRT, ﬁrst
the KD for the PaHisGS-PaHisZ complex had to be measured
in glycerol (Figure S7), and data ﬁtting to eq 1 yielded KD’s of
1.3 ± 0.1, 1.1 ± 0.2, and 0.5 ± 0.1 μM in 0%, 18%, and 27%
glycerol, respectively. Knowledge of the KD’s allowed
calculation, using eq 2, of PaATPPRT concentrations at
diﬀerent glycerol concentrations for measurement of kcat. In
contrast to the eﬀect on PaHisGS, increasing solvent viscosity
resulted in a decrease of up to 2.5-fold in PaATPPRT kcat, with
negligible eﬀects on kcat/KM for either substrate, as shown in
Figure 7B and Table S7. This points to product dissociation
from PaATPPRT as the rate-limiting step in the reaction, as is
the case with HisGL ATPPRTs.
8,50
Burst in Product Formation by PaATPPRT. To glean
additional support for distinct rate-limiting steps controlling
nonactivated and activated PaHisGS reactions, product
formation time courses were monitored under pre-steady-
state conditions for PaHisGS and PaATPPRT (Figure 8).
PRATP formation with PaHisGS varies linearly with time with
a steady-state rate constant of 0.091 ± 0.001 s−1, in reasonable
agreement with kcat (Tables S3, S4, S6). This rules out a slow
step after formation of enzyme-bound products51 and suggests
interconversion between ternary complexes (k5 + k6 in Scheme
2) is rate-limiting.
On the other hand, a burst in PRATP formation precedes
the steady-state with PaATPPRT, and data ﬁtting to eq 7
yielded a kburst of 80 ± 1 s
−1, a steady-state rate constant of
Figure 7. Solvent viscosity eﬀects on steady-state kinetics determined
at 0% (green), 18% (pink), and 27% (cyan) glycerol (v/v). (A)
PaHisGS saturation curves (top) and steady-state constants (bottom)
dependence on glycerol concentration. (B) PaATPPRT saturation
curves (top) and steady-state constants (bottom) dependence on
glycerol concentration. Data represent either mean ± SE (scatter
plots) or value ± ﬁtting error (bar plots). Lines are data ﬁtting to eq 3.
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1.11 ± 0.01 s−1, and an A0 of 4.3 μM. This is consistent with a
step after chemistry, likely product release (k′7 in Scheme 2),
limiting the reaction rate,51,52 in agreement with the conclusion
drawn from solvent viscosity eﬀects. M. tuberculosis HisGL
ATPPRT also displays a burst in product formation with a
kburst of 0.67 s
−1 at 25 °C.8 Thus, PaATPPRT kburst at 20 °C is
over 119-fold higher than M. tuberculosis HisGL ATPPRT’s at
25 °C, which may be a feature of HisGS ATPPRTs and/or a
consequence of PaATPPRT being psychrophilic.26
The amplitude of the burst phase (A0) generally reﬂects the
concentration of the Michaelis complex, which at saturating
substrate concentrations could be as high as the concentration
of enzyme.53 The A0 of 4.3 μM is over 4.4-fold lower than the
concentration of PaATPPRT used in the experiment (19 μM).
Two main reasons may account, separately or in combination,
for this result without invoking the unlikely scenario where ca.
75% of enzyme molecules are inactive. First, the enzyme might
not be fully saturated by one or both substrates, which would
also explain the steady-state rate constant being slightly smaller
than the kcat values extrapolated from substrate saturation
curves. This may be the case with the PaHisGS steady-state
rate constant as well. Second, chemical reversibility decreases
A0. Both kburst and A0 are dependent on all rate constants
depicted in Scheme 2, the forward and reverse rate constants
for interconversion between enzyme-bound substrates and
products, k5 and k6, respectively, and the net rate constant for
release of products from the enzyme, k′7, according to eqs 9
and 10.51
= + + ′k k k kburst 5 6 7 (9)
= + ′
+ + ′
A
k k k
k k k
( )
( )0
5 6 7
5 6 7
2
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Upon inspection of eqs 9 and 10, one must conclude that
under the most favorable conditions, full expression of A0 can
only occur when chemistry is irreversible (k6 = 0) and much
faster than product release (k5 ≫ k′7). Internal reversibility,
described by the magnitude of k6, will increase kburst while
decreasing A0. Equilibrium in the ATPPRT reaction strongly
favors the reactants,17 making it possible for the crystal
structure of the PaATPPRT-PRPP-ATP ternary-complex to be
attained with wild-type enzyme.29 Hence, k6 is likely to be
much larger than k5, making k6 the main contributor to kburst
and signiﬁcantly reducing A0 from its theoretical upper limit of
19 μM. Relative contributions of k5 and k6 to kburst and A0
notwithstanding, it is clear that activation of PaHisGS by
PaHisZ switches the rate-limiting step of the reaction from
interconversion between the ternary complexes to product
release.
PaHisZ-Induced Shift in the Rate-Limiting Step. The
results presented here demonstrate that two long-established
mechanistic features of HisGL ATPPRTs, namely, ATP as the
ﬁrst substrate to bind to the enzyme and ADP as an
Figure 8. Pre-steady-state kinetics with PaATPPRT and PaHisGS,
with a burst in product formation observed with the former but not
the latter. Black lines are data ﬁtting to eq 7 for PaATPPRT and a
linear regression for PaHisGS.
Scheme 2. Interpretation of the Pre-Steady-State of
PaHisGS and PaATPPRT Reactions
Scheme 3. Kinetic Mechanism and Rate-Limiting Steps of PaHisGS (top) and PaATPPRT (bottom) Reactions and the
Corresponding Crystal Structures26,29 a
aThe second PaHisGS homodimers lie behind the PaHisZ tetramers.
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inhibitor,16,19,21,22,33 do not apply to PaHisGS, and possibly
other HisGS ATPPRTs. Providing functional data to support
hypotheses proposed based on extensive crystallography work
on PaHisGS and PaATPPRT,
29 PaHisGS is shown to be able to
replace ATP for ADP as a substrate and to operate by a steady-
state ordered mechanism where PRPP is the ﬁrst substrate to
bind to the enzyme (Scheme 3). PaHisGS kcat increases when
Mn2+ replaces Mg2+, which can be accounted for owing to
more eﬃcient charge stabilization by Mn2+ upon leaving group
departure at the transition state. The observation that
PaATPPRT steady-state kinetics is unaltered with Mn2+ raises
the possibility of kcat’s for the activated and nonactivated
enzyme forms reporting on distinct steps. This is conﬁrmed by
solvent viscosity eﬀects on steady-state parameters and by pre-
steady-state kinetics under multiple-turnover conditions, which
indicate that interconversion between PaHisGS−PRPP-ATP
and PaHisGS−PRATP-PPi complexes limits the reaction rate
for the nonactivated enzyme, likely with a signiﬁcant
contribution from chemistry given the eﬀect of Mn2+.
However, allosteric activation by PaHisZ accelerates this
interconversion well beyond the steady-state rate, which now
reﬂects the oﬀ-rate of either PPi from the PaATPPRT−
PRATP-PPi ternary complex or PRATP from the
PaATPPRT−PRATP binary complex (Scheme 3). This
provides fundamental insight into the allosteric regulation of
a complex multiprotein enzyme.
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